| Primary |
| Hypertension |
44.9% |
| Product Used For Unknown Indication |
14.6% |
| Cardiac Failure Chronic |
9.1% |
| Univentricular Heart |
8.6% |
| Diabetes Mellitus |
4.0% |
| Obesity |
3.0% |
| Cardiac Failure |
2.5% |
| Low Density Lipoprotein Increased |
1.5% |
| Arteriosclerosis |
1.0% |
| Arthralgia |
1.0% |
| Blood Pressure |
1.0% |
| Blood Triglycerides |
1.0% |
| Cerebrovascular Accident Prophylaxis |
1.0% |
| Hypertensive Cardiomyopathy |
1.0% |
| Osteoarthritis |
1.0% |
| Osteoporosis Prophylaxis |
1.0% |
| Pain |
1.0% |
| Renal Artery Stenosis |
1.0% |
| Thrombosis Prophylaxis |
1.0% |
| Affective Disorder |
0.5% |
|
| Overdose |
14.4% |
| Rhabdomyolysis |
11.5% |
| Hyponatraemia |
10.6% |
| Renal Failure Acute |
8.7% |
| Hypokalaemia |
6.7% |
| Dyspnoea |
5.8% |
| Syncope |
5.8% |
| Vomiting |
4.8% |
| Swollen Tongue |
3.8% |
| Urinary Tract Infection |
3.8% |
| Acute Prerenal Failure |
2.9% |
| Drug Ineffective |
2.9% |
| Hyperkalaemia |
2.9% |
| Liver Disorder |
2.9% |
| Therapeutic Agent Toxicity |
2.9% |
| Blood Urea Increased |
1.9% |
| Hypertension |
1.9% |
| Hypovolaemia |
1.9% |
| Liver Injury |
1.9% |
| Pancreatitis |
1.9% |
|
| Secondary |
| Hypertension |
38.1% |
| Product Used For Unknown Indication |
11.5% |
| Cardiac Failure Chronic |
8.3% |
| Univentricular Heart |
7.8% |
| Diabetes Mellitus Non-insulin-dependent |
5.0% |
| Headache |
3.7% |
| Breast Cancer |
2.8% |
| Diabetes Mellitus |
2.8% |
| Type 2 Diabetes Mellitus |
2.8% |
| Hyperlipidaemia |
2.3% |
| Bypass Surgery |
1.8% |
| Non-small Cell Lung Cancer |
1.8% |
| Pain |
1.8% |
| Prostatic Adenoma |
1.8% |
| Blood Pressure |
1.4% |
| Bowel Preparation |
1.4% |
| Cardiovascular Event Prophylaxis |
1.4% |
| Dyslipidaemia |
1.4% |
| Gastric Ulcer |
1.4% |
| Arteriosclerosis |
0.9% |
|
| Renal Failure Acute |
16.1% |
| Presyncope |
7.1% |
| Thyroid Disorder |
7.1% |
| Overdose |
5.4% |
| Pancreatitis Chronic |
5.4% |
| Pulmonary Valve Stenosis |
5.4% |
| Renal Tubular Necrosis |
5.4% |
| Urosepsis |
5.4% |
| Visual Disturbance |
5.4% |
| Vomiting |
5.4% |
| Electrolyte Imbalance |
3.6% |
| Headache |
3.6% |
| Malaise |
3.6% |
| Metabolic Alkalosis |
3.6% |
| Myocardial Infarction |
3.6% |
| Renal Failure |
3.6% |
| Respiratory Failure |
3.6% |
| Toxicity To Various Agents |
3.6% |
| Adverse Event |
1.8% |
| Anaphylactic Reaction |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.2% |
| Hypertension |
17.0% |
| Pain |
5.1% |
| Arthralgia |
4.4% |
| Blood Cholesterol Increased |
4.4% |
| Prophylaxis |
4.4% |
| Rheumatoid Arthritis |
4.2% |
| Back Pain |
4.2% |
| Diabetes Mellitus |
3.8% |
| Drug Use For Unknown Indication |
3.8% |
| Blood Pressure |
3.7% |
| Infection Prophylaxis |
3.3% |
| Arthritis |
3.2% |
| Gastrooesophageal Reflux Disease |
3.0% |
| Asthma |
2.8% |
| Anxiety |
2.4% |
| Osteoarthritis |
2.4% |
| Glaucoma |
2.3% |
| Fibromyalgia |
2.2% |
| Depression |
2.1% |
|
| Vomiting |
11.4% |
| Weight Increased |
9.8% |
| Myocardial Infarction |
9.3% |
| Rhabdomyolysis |
7.3% |
| Pulmonary Embolism |
6.7% |
| Weight Decreased |
6.2% |
| Urinary Tract Infection |
5.2% |
| Myalgia |
4.7% |
| Ventricular Hypertrophy |
4.1% |
| Walking Aid User |
4.1% |
| Sleep Apnoea Syndrome |
3.6% |
| Vertebral Wedging |
3.6% |
| Cerebrovascular Accident |
3.1% |
| Paraesthesia |
3.1% |
| Syncope |
3.1% |
| Thrombosis |
3.1% |
| Transient Ischaemic Attack |
3.1% |
| Wheezing |
3.1% |
| Dyspnoea |
2.6% |
| Fatigue |
2.6% |
|
| Interacting |
| Fibromyalgia |
20.0% |
| Glaucoma |
20.0% |
| Hypertension |
20.0% |
| Macular Degeneration |
20.0% |
| Reflux Oesophagitis |
20.0% |
|
| Myalgia |
50.0% |
| Vomiting |
50.0% |
|
